Corimmun is a drug development company focused on therapeutics and diagnostics for heart and vascular diseases.
Corimmun is a clinical drug developing company located in Martinsried near Munich, Germany, and is focused on novel therapeutics and diagnostics for heart and vascular diseases. Corimmun's activities and experiences comprise all steps from research to drug development and commercialization.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 22, 2007 | Seed | €680K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Bayern Kapital | — | Seed |